BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26168105)

  • 1. The Use of Parenteral Iron Therapy for the Treatment of Postpartum Anemia.
    Nash CM; Allen VM
    J Obstet Gynaecol Can; 2015 May; 37(5):439-442. PubMed ID: 26168105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial.
    Perelló MF; Coloma JL; Masoller N; Esteve J; Palacio M
    BJOG; 2014 May; 121(6):706-13. PubMed ID: 24423186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia during pregnancy and in the postpartum: intravenous iron therapy revisited.
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123 Suppl 2():S1-35. PubMed ID: 16360535
    [No Abstract]   [Full Text] [Related]  

  • 4. Should intravenous iron be upfront therapy for iron deficiency anemia?
    Auerbach M
    Pediatr Blood Cancer; 2011 Apr; 56(4):511-2. PubMed ID: 21298731
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial.
    Froessler B; Cocchiaro C; Saadat-Gilani K; Hodyl N; Dekker G
    J Matern Fetal Neonatal Med; 2013 May; 26(7):654-9. PubMed ID: 23130909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous versus oral iron therapy for postpartum anaemia.
    Bhandal N; Russell R
    BJOG; 2006 Nov; 113(11):1248-52. PubMed ID: 17004982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea.
    Han YM; Yoon H; Shin CM; Koh SJ; Im JP; Kim BG; Kim JS; Jung HC
    Gut Liver; 2016 Jul; 10(4):562-8. PubMed ID: 27021505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral vs intravenous iron therapy for postpartum anemia: a systematic review and meta-analysis.
    Sultan P; Bampoe S; Shah R; Guo N; Estes J; Stave C; Goodnough LT; Halpern S; Butwick AJ
    Am J Obstet Gynecol; 2019 Jul; 221(1):19-29.e3. PubMed ID: 30578747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial.
    Seid MH; Derman RJ; Baker JB; Banach W; Goldberg C; Rogers R
    Am J Obstet Gynecol; 2008 Oct; 199(4):435.e1-7. PubMed ID: 18928998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia.
    Pfenniger A; Schuller C; Christoph P; Surbek D
    J Perinat Med; 2012 Apr; 40(4):397-402. PubMed ID: 22752771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous Iron Sucrose Therapy in Iron Deficiency Anemia in Antenatal and Postnatal Patients.
    Sharma J; Tiwari S
    JNMA J Nepal Med Assoc; 2015; 53(198):104-7. PubMed ID: 26994029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral iron therapy options.
    Silverstein SB; Rodgers GM
    Am J Hematol; 2004 May; 76(1):74-8. PubMed ID: 15114602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the efficacy of intravenous iron III-hydroxide saccharate for treating adult patients with iron deficiency anemia].
    Cançado RD; Brasil SA; Noronha TG; Chiattone CS
    Rev Assoc Med Bras (1992); 2005; 51(6):323-8. PubMed ID: 16444338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of available intravenous iron preparations in hemodialysis.
    Palmer K; Cameron K; Battistella M
    CANNT J; 2013; 23(2):51-4; quiz 55-6. PubMed ID: 24069699
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative rates of adverse events with different formulations of intravenous iron.
    Okam MM; Mandell E; Hevelone N; Wentz R; Ross A; Abel GA
    Am J Hematol; 2012 Nov; 87(11):E123-4. PubMed ID: 22965928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Total Dose Infusion of Iron Intravenously in Patients With Acute Heart Failure and Anemia (Hemoglobin < 13 g/dl).
    Kaminsky BM; Pogue KT; Hanigan S; Koelling TM; Dorsch MP
    Am J Cardiol; 2016 Jun; 117(12):1942-6. PubMed ID: 27161817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral or intravenous iron for anemia correction in chronic kidney disease?
    Drüeke TB; Massy ZA
    Kidney Int; 2015 Oct; 88(4):673-5. PubMed ID: 26422625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous iron treatments for iron deficiency anemia in inflammatory bowel disease: a budget impact analysis of iron isomaltoside 1000 (Monofer) in the UK.
    Pollock RF; Muduma G
    Expert Opin Drug Deliv; 2017 Dec; 14(12):1439-1446. PubMed ID: 29032713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of intravenous iron in anemia management and transfusion avoidance.
    Auerbach M; Goodnough LT; Picard D; Maniatis A
    Transfusion; 2008 May; 48(5):988-1000. PubMed ID: 18346021
    [No Abstract]   [Full Text] [Related]  

  • 20. Parenteral iron therapy: a single institution's experience over a 5-year period.
    Laman CA; Silverstein SB; Rodgers GM
    J Natl Compr Canc Netw; 2005 Nov; 3(6):791-5. PubMed ID: 16316614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.